Content about Tris Pharma

April 3, 2013

FDA approves new allergy drug for children

The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said.

August 28, 2012

Perrigo, Tris Pharma launch generic cough-cold product

Perrigo and Tris Pharma have launched a private-label version of Delsym extended-release oral liquid suspension containing dextromethorphan polistirex.

May 31, 2012

Tris Pharma, Perrigo to bring Delsym generic equivalent to market

Tris Pharma on Thursday announced that the Food and Drug Administration has approved its generic equivalent to Reckitt Benckiser's Delsym, an extended-release oral liquid suspension containing dextromethorphan.

June 29, 2011

Tris Pharma names VP human resources

A specialty pharmaceutical company has appointed a new VP human resources.

March 29, 2011

MyKidz Iron re-enters market

Tris Pharma on Tuesday announced its relaunch of the MyKidz Iron product line, which includes two supplement products and one prescription-only product.

March 9, 2011

Tris seeks FDA OK for allergy treatment for kids

The Food and Drug Administration has accepted a regulatory approval application from Tris Pharma for a drug to treat allergies in children ages 2 years and older, Tris said Wednesday.

October 4, 2010

FDA approves Par and Tris Pharma's generic Tussionex

The Food and Drug Administration has approved a generic treatment for cough and upper respiratory...

May 5, 2010

Perrigo acquires rights to generic Delsym cough syrup

Perrigo on Wednesday announced that it has acquired the exclusive U.S. store brand rights to...